Anti-viral defence by an mRNA ADP-ribosyltransferase that blocks translation
Nature,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 23, 2024
Abstract
Host–pathogen
conflicts
are
crucibles
of
molecular
innovation
1,2
.
Selection
for
immunity
to
pathogens
has
driven
the
evolution
sophisticated
mechanisms
throughout
biology,
including
in
bacterial
defence
against
bacteriophages
3
Here
we
characterize
widely
distributed
anti-phage
system
CmdTAC,
which
provides
robust
infection
by
T-even
family
phages
4
Our
results
support
a
model
CmdC
detects
sensing
viral
capsid
proteins,
ultimately
leading
activation
toxic
ADP-ribosyltransferase
effector
protein,
CmdT.
We
show
that
newly
synthesized
protein
triggers
dissociation
chaperone
from
CmdTAC
complex,
destabilization
and
degradation
antitoxin
CmdA,
with
consequent
liberation
CmdT
ADP-ribosyltransferase.
Notably,
does
not
target
DNA
or
structured
RNA,
known
targets
other
ADP-ribosyltransferases.
Instead,
modifies
N6
position
adenine
GA
dinucleotides
within
single-stranded
RNAs,
arrest
mRNA
translation
inhibition
replication.
work
reveals
novel
mechanism
anti-viral
previously
unknown
but
broadly
class
ADP-ribosyltransferases
mRNA.
Language: Английский
Chromosomal integrons are genetically and functionally isolated units of genomes
Nucleic Acids Research,
Journal Year:
2024,
Volume and Issue:
52(20), P. 12565 - 12581
Published: Sept. 23, 2024
Abstract
Integrons
are
genetic
elements
that
increase
the
evolvability
of
bacteria
by
capturing
new
genes
and
stockpiling
them
in
arrays.
Sedentary
chromosomal
integrons
(SCIs)
can
be
massive
highly
stabilized
structures
encoding
hundreds
genes,
whose
function
remains
generally
unknown.
SCIs
have
co-evolved
with
host
for
aeons
intertwined
their
physiology
from
a
mechanistic
point
view.
But,
paradoxically,
other
aspects,
like
variable
content
location
within
genome,
suggest
high
functional
independence.
In
this
work,
we
explored
connection
to
genome
using
as
model
Superintegron
(SI),
179-cassette
long
SCI
Vibrio
cholerae
N16961.
We
relocated
deleted
SI
SeqDelTA,
novel
method
allows
counteract
strong
stabilization
conferred
toxin–antitoxin
systems
array.
characterized
depth
impact
V.
cholerae’s
physiology,
measuring
fitness,
chromosome
replication
dynamics,
persistence,
transcriptomics,
phenomics,
natural
competence,
virulence
resistance
against
protist
grazing.
The
deletion
did
not
produce
detectable
effects
any
condition,
proving
that—despite
millions
years
co-evolution—SCIs
genetically
functionally
isolated
units
genomes.
Language: Английский
Isolation, Characterization, and Unlocking the Potential of Mimir124 Phage for Personalized Treatment of Difficult, Multidrug-Resistant Uropathogenic E. coli Strain
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(23), P. 12755 - 12755
Published: Nov. 27, 2024
Escherichia
coli
and
its
bacteriophages
are
among
the
most
studied
model
microorganisms.
Bacteriophages
for
various
E.
strains
can
typically
be
easily
isolated
from
environmental
sources,
many
of
these
viruses
harnessed
to
combat
infections
in
humans
animals.
However,
some
relatively
rare
pose
significant
challenges
finding
suitable
phages.
The
uropathogenic
strain
UPEC124,
a
patient
suffering
neurogenic
bladder
dysfunction,
was
found
resistant
all
coliphages
our
collections,
initial
attempts
isolate
new
phages
failed.
Using
an
improved
procedure
phage
enrichment,
we
N4-related
Mimir124,
belonging
Gamaleyavirus
genus,
which
able
lyse
this
“difficult”
strain.
Although
Mimir124
is
narrow-spectrum
phage,
it
effective
individualized
treatment
patient,
leading
pathogen
eradication.
primary
receptor
O
antigen
O101
type;
consequently,
Mimir124-resistant
clones
were
rough
(having
lost
antigen).
These
clones,
however,
gained
sensitivity
that
recognize
outer
membrane
proteins
as
receptors.
Despite
presence
nine
potential
antiviral
systems
genome
UPEC124
strain,
difficulty
largely
due
efficient,
non-specific
cell
surface
protection
provided
by
antigen.
results
highlight
importance
approach
therapy,
where
narrow
host-range
phages—typically
avoided
pre-fabricated
cocktails—may
instrumental.
Furthermore,
study
illustrates
how
integrating
genomic,
structural,
functional
insights
guide
development
innovative
therapeutic
strategies,
paving
way
broader
applications
therapy
combating
multidrug-resistant
bacterial
pathogens.
Language: Английский
Standardization of the Agar Plate Method for Bacteriophage Production
Su Jin Jo,
No information about this author
Young Min Lee,
No information about this author
K. K. Cho
No information about this author
et al.
Antibiotics,
Journal Year:
2024,
Volume and Issue:
14(1), P. 2 - 2
Published: Dec. 24, 2024
The
growing
threat
of
antimicrobial
resistance
(AMR),
exacerbated
by
the
COVID-19
pandemic,
highlights
urgent
need
for
alternative
treatments
such
as
bacteriophage
(phage)
therapy.
Phage
therapy
offers
a
targeted
approach
to
combat
bacterial
infections,
particularly
those
resistant
conventional
antibiotics.
This
study
aimed
standardize
an
agar
plate
method
high-mix,
low-volume
phage
production,
suitable
personalized
Plaque
assays
were
conducted
with
double-layer
method,
and
plaque
sizes
precisely
measured
using
image
analysis
tools.
Regression
models
developed
Minitab
software
established
correlations
between
size
optimizing
production
while
minimizing
development.
resulting
Size
Calculation
(PSC)
model
accurately
correlated
inoculum
concentration
yield,
establishing
specific
plaque-forming
unit
(PFU)
thresholds
optimal
production.
Using
phages
targeting
pathogens
Escherichia,
Salmonella,
Staphylococcus,
Pseudomonas,
Chryseobacterium,
Vibrio,
Erwinia,
Aeromonas
confirmed
model's
accuracy
across
various
conditions.
validation
showed
strong
inverse
correlation
minimum-lawn
cell
clearing
PFUs
(MCPs;
R²
=
98.91%)
identified
density
that
maximizes
yield
evolution
mutants.
These
results
highlight
PSC
standardized
scalable
efficient
which
is
crucial
AMR
management.
Furthermore,
its
adaptability
different
conditions
positions
it
potential
standard
tool
rapid
precise
screening
propagation
in
both
clinical
industrial
settings.
Language: Английский